Results 21 to 30 of about 178,848,266 (217)

Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw

open access: yesDentistry Journal, 2021
Medication-related osteonecrosis of the jaw (MRONJ) frequently affects patients after treatments with bisphosphonates or denosumab, especially with high doses in patients with bone osteoporosis, neoplastic metastases, or possibly anti-angiogenic ...
Antonio Cortese   +3 more
doaj   +1 more source

Local delivery of hydrogel encapsulated vascular endothelial growth factor for the prevention of medication-related osteonecrosis of the jaw [PDF]

open access: yes, 2021
The anti-angiogenic effects of bisphosphonates have been hypothesized as one of the major etiologic factors in the development of medication-related osteonecrosis of the jaw (MRONJ), a severe debilitating condition with limited treatment options.
Petcu, Eugen Bogdan   +5 more
core   +1 more source

The Prevention of Medication-related Osteonecrosis of the Jaw [PDF]

open access: yesDeutsches Ärzteblatt international, 2017
Medication-related osteonecrosis of the jaw (MRONJ) is a preventable complication of antiresorptive treatment. It arises in 1-20% of patients with bone metastases of solid tumors and hematologic malignancies and in 0.1-2% of patients being treated for osteoporosis with bisphosphonates. Depending on the underlying disease and medication dosage, the risk
Poxleitner, Philipp   +3 more
openaire   +3 more sources

Medication‐related osteonecrosis of the jaw leading to sepsis in a patient with rheumatoid arthritis: A case report and clinical implications

open access: yesClinical Case Reports, 2023
Key Clinical Message Chronic use of bisphosphonates, in combination with immunosuppressive therapy, increases the risk of jaw osteonecrosis. When sepsis occurs in patients receiving bisphosphonate, osteonecrosis of the jaw should be considered a ...
Kazuhiko Iwasaki, Akihito Okazaki
doaj   +1 more source

Fatal infectious encephalitis as a complication of medication-related osteonecrosis of the jaw

open access: yesOral and Maxillofacial Surgery Cases, 2020
We present a unique case of bacterial encephalitis in a 79-year-old female due to progression of medication-related osteonecrosis of the jaw. The occurrence of this life-threatening neurologic condition following the expansion of medication-related ...
Hye-Won Kim   +3 more
doaj   +1 more source

The Use of Photodynamic Therapy on Medication-Related Osteonecrosis of the Jaws: Animal Study

open access: yesBalkan Journal of Dental Medicine, 2021
Background/Aim: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) was first introduced in 2003 and its scope was expanded by the name medication-related osteonecrosis of the jaw (MRONJ), since 2014.
Karapinar Gökay   +3 more
doaj   +1 more source

Osteonecrosis of The Jaw; Medication- Related Osteonecrosis of the jaw (MRONJ)

open access: yesSONDE (Sound of Dentistry), 2021
Sejak tahun 2004, dilaporkan terjadinya osteonecrosis of the jaw pada pasien osteoporosis yang mengkonsumsi bifosfonat, walaupun hal tersebut lebih sedikir dibandingkan kejadian osteonecrosis of the jaw pada penderita kanker yang mendapat terapi bifosfonat secara intravena.
openaire   +2 more sources

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)

open access: yesJapanese Dental Science Review, 2019
Summary: Generally, CT and MR images of antiresorptive agent-related osteonecrosis of the jaw (ARONJ)/medication-related osteonecrosis of the jaw (MRONJ) show nonspecific findings as seen in active osteomyelitis.However, there are some characteristics as
Akira Baba   +6 more
doaj   +1 more source

Medication-related osteonecrosis of the jaw: An update

open access: yesNational Journal of Maxillofacial Surgery, 2022
Antiresorptive medications, such as bisphosphonates and denosumab, are an important class of medication used to treat a wide range of diseases from osteoporosis to multiple myeloma. Unfortunately, they are also associated with a rare but devastating side effect - medication-related osteonecrosis of the jaw (MRONJ). First reported in 2003, much research
openaire   +2 more sources

Plasma Therapy for Medication-Related Osteonecrosis of the Jaws- A Case Report

open access: yesCase Reports in Clinical Practice, 2023
Medication-related osteonecrosis of the jaw (MRONJ) is a side effect of anti-bone resorption medications. Nowadays antiresorptive medications like bisphosphonate and monoclonal antibodies like denosumab that have been prescribed for bone disorders and ...
Maryam Jalili Sadrabad, Elham Saberian
doaj   +1 more source

Home - About - Disclaimer - Privacy